Thomson Reuters
    EN : JP : CN : KR : ES : PT   
 
 
 
IDRAC: United States


 

The complete resource for FDA drug and biological advisory committee and workshop meetings. IDRAC features access to the AdComm BulletinTM, AdComm Profiles, AdComm Voting, and the FDA Workshop Bulletin. There is also key information on:

  • Ethical drugs (brand name and generic)
  • Over-the-counter drugs (followed from brand to OTC switch only)
  • Biological therapies
  • Medical devices
  • Combination products
  • The Code of Federal Regulations (CFR), updated weekly

 

For more information, download our US module factsheet.





 


 

Options

 
Disclaimer | Terms of Use
Privacy Policy | Copyright